Utilization of extended-spectrum β-lactamase (ESBL) detection systems in microbiology laboratories: Survey of Connecticut hospitals from 1998-2002

Connecticut Medicine

Volumn 67, Issue 3, 2003, Pages 149-152

  Dandekar, Prachi K ^a   Barrett, Nancy L ^b   Nightingale, Charles H ^a   Nicolau, David P ^a  

^a HARTFORD HOSPITAL   (United States)

^b CDC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE; CEFOTAXIME; CEFPODOXIME PROXETIL; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; DRUG METABOLIZING ENZYME;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DRUG HYDROLYSIS; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HEALTH SURVEY; HOSPITAL; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA; LABORATORY TEST; MICROBIOLOGICAL EXAMINATION; NONHUMAN; SCREENING; TREATMENT FAILURE;

AZTREONAM; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CONNECTICUT; ESCHERICHIA COLI; HUMANS; KLEBSIELLA PNEUMONIAE; LABORATORIES; MICROBIAL SENSITIVITY TESTS; UNITED STATES;

EID: 0037344730     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Bush K: Characterization of beta-lactamases. Antimicrob Agents Chemother 1989; 33:259-63.
2. Paterson DL, Ko WC, Von Gottberg, et al: Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended spectrum beta-lactamases: Implications for clinical microbiology laboratory. J Clin Microbiol 2001; 39:2206-12.
3. Wong-Beringer A, Hindler J, Loeloff M, et al: Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime. Clin Infect Dis 2002; 34:1335-146.
4. Smith CE, Tillman S, Howell AW, et al: Failure of ceftazidimeamikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. Antimicrob Agents Chemother 1990; 34:1290-3.
5. Quinn JP, Miyashiro D, Sahm D, et al: Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989; 33:1451-6.
6. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. NCCLS approved standard M100-S12. National Committee for Clinical Laboratory Standards, Wayne PA.
7. CDC: Laboratory capacity to detect antimicrobial resistance, 1998. MMWR Morb Wkly Rep. 2000; 48:51-52:1167-71.
8. Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF: Detection and reporting of organisms producing extended-spectrum beta-lactamases: Survey of laboratories in Connecticut. J Clin Microbiol 1999; 37:4065-70.